TargetMol

Proparacaine hydrochloride

Product Code:
 
TAR-T0222
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0222-50mg50mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0222-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0222-100mg100mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0222-200mg200mg£128.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Proparacaine Hydrochloride is the hydrochloride salt form of proparacaine, a benzoic acid derivative with local anesthetic property. Proparacaine hydrochloride stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby inhibiting sodium ion influx required for the initiation and conduction of impulses within the neuronal cell, and resulting in a loss of sensation.
CAS:
5875-06-9
Formula:
C16H26N2O3?HCl
Molecular Weight:
330.86
Pathway:
Apoptosis; Membrane transporter/Ion channel
Purity:
0.9987
SMILES:
Cl.CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC
Target:
Apoptosis; Sodium Channel

References

1. Grant RL, et al. Exp Eye Res, 1994, 58(4), 469-478. 2. Segarra S, et al. Vet Ophthalmol, 2011, Suppl 1, 5-8. 3. Dass BA, et al. J Ocul Pharmacol, 1988, 4(3), 187-194. 4. Hung CH, et al. Neurosci Lett, 2009, 454(3), 249-253.